Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation (Q34298262)

1 August 2017

1 reference

title

Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation (English)

1 reference

1 August 2017

1

Champlin R

1 reference

1 August 2017

9

Giralt S

1 reference

1 August 2017

2

Khouri I

1 reference

1 August 2017

Anderlini P

3

1 reference

1 August 2017

Gajewski J

4

1 reference

1 August 2017

Kornblau S

5

1 reference

1 August 2017

Molldrem J

6

1 reference

1 August 2017

Shimoni A

7

1 reference

1 August 2017

Ueno N

8

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Bone Marrow Transplantation

1 August 2017

published in

1 reference

1 August 2017

volume

27 Suppl 2

1 reference

1 August 2017

page(s)

S13-22

1 reference

Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

How does bone-marrow transplantation cure leukaemia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Identical-twin bone marrow transplants for leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Donor-recipient polymorphism of the proteinase 3 gene: a potential target for T-cell alloresponses to myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

T cell subsets and graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Graft-versus-host disease: the influence of type 1 and type 2 T cell cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Alloreactive CD4+ T lymphocytes can exert cytotoxicity to chronic myeloid leukaemia cells processing and presenting exogenous antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Sequential molecular monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusion for relapse after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Donor leucocyte transfusions for relapse in myelodyplastic syndrome after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Mini-allografts: ongoing trials in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Antigen presentation: a balanced diet

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Mixed hematopoietic chimerism after hematopoietic stem cell allografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Reduction in the frequency of transplant-related complications in patients with chronic myeloid leukemia undergoing BMT preconditioned with a new, non-myeloablative drug combination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Achievement of complete cytogenetic remission after two very low-dose donor leucocyte infusions in a patient with extensive cGVHD relapsing in accelerated phase post allogeneic BMT for CML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Transplantation of anergic histoincompatible bone marrow allografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Specific depletion of alloreactive T cells in HLA-identical siblings: a method for separating graft-versus-host and graft-versus-leukaemia reactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Generation of leukemia-reactive cytotoxic T lymphocytes from HLA-identical donors of patients with chronic myeloid leukemia using modifications of a limiting dilution assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702864

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1702864

1 reference

Dimensions Publication ID

1 August 2017

1038009961

0 references

1 reference